BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19140316)

  • 1. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
    Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
    Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.
    Senchenko VN; Anedchenko EA; Kondratieva TT; Krasnov GS; Dmitriev AA; Zabarovska VI; Pavlova TV; Kashuba VI; Lerman MI; Zabarovsky ER
    BMC Cancer; 2010 Mar; 10():75. PubMed ID: 20193080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
    Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
    Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.
    Li J; Wang F; Haraldson K; Protopopov A; Duh FM; Geil L; Kuzmin I; Minna JD; Stanbridge E; Braga E; Kashuba VI; Klein G; Lerman MI; Zabarovsky ER
    Cancer Res; 2004 Sep; 64(18):6438-43. PubMed ID: 15374952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor suppressor gene RBSP3 in cervical carcinoma: copy number and transcriptional level].
    Anedchenko EA; Kiseleva NP; Dmitriev AA; Kiselev FL; Zabarovskiĭ ER; Senchenko VN
    Mol Biol (Mosk); 2007; 41(1):86-95. PubMed ID: 17380895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
    Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
    Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
    Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.
    Wang F; Grigorieva EV; Li J; Senchenko VN; Pavlova TV; Anedchenko EA; Kudryavtseva AV; Tsimanis A; Angeloni D; Lerman MI; Kashuba VI; Klein G; Zabarovsky ER
    PLoS One; 2008 Aug; 3(8):e3031. PubMed ID: 18725949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus.
    Boelens MC; van den Berg A; Vogelzang I; Wesseling J; Postma DS; Timens W; Groen HJ
    J Clin Pathol; 2007 Jun; 60(6):608-14. PubMed ID: 16489176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.
    Senchenko VN; Kisseljova NP; Ivanova TA; Dmitriev AA; Krasnov GS; Kudryavtseva AV; Panasenko GV; Tsitrin EB; Lerman MI; Kisseljov FL; Kashuba VI; Zabarovsky ER
    Epigenetics; 2013 Apr; 8(4):409-20. PubMed ID: 23478628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
    Warnecke-Eberz U; Bollschweiler E; Drebber U; Pohl A; Baldus SE; Hoelscher AH; Metzger R
    Oncol Rep; 2008 Sep; 20(3):619-24. PubMed ID: 18695914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
    Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
    Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
    Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
    Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
    Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
    Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.